Who are Atmobiosciences's investors?

Atmobiosciences's investors include Breakthrough Victoria.

Where is Atmobiosciences headquartered?

Atmobiosciences is headquartered in New York City, US.

Atmobiosciences

New York City, US · 1 known investors

Find your way into Atmobiosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Atmobiosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.

Biotech Healthtech Medical Devices

Founders & leadership

Mal HebblewhiteCEO

Investors · 1

Breakthrough Victorialisted by Breakthrough VictoriaMelbourne

How we know: Breakthrough Victoria's portfolio page · Not right? Tell us

Frequently asked questions

What does Atmobiosciences do?: Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.
Who are Atmobiosciences's investors?: Atmobiosciences's investors include Breakthrough Victoria.
Where is Atmobiosciences headquartered?: Atmobiosciences is headquartered in New York City, US.